i
Risk of Guillain-Barré syndrome (GBS) following recombinant zoster vaccine (RZV)
-
February 25, 2021
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subjects:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
Supporting Files
-
No Additional Files
More +